Literature DB >> 5570706

Unfavourable effects of long-term adjuvant chemotherapy with Endoxan in radically operated bronchogenic carcinoma.

K W Brunner, T Marthaler, W Müller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5570706     DOI: 10.1016/0014-2964(71)90071-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  7 in total

1.  Suppression of in vitro peripheral blood lymphocyte mitogenesis by cytotoxic drugs commonly used in the treatment of breast cancer: a comparative study.

Authors:  M Gereis; A P Burford-Mason; S M Watkins
Journal:  Agents Actions       Date:  1987-12

2.  Oral administration of BCG as an adjuvant to surgical treatment of carcinoma of the bronchus.

Authors:  A B Miller; H E Taylor; M A Baker; D J Dodds; R Falk; A Frappier; D P Hill; A Jindani; S Landi; A S Macdonald; J W Thomas; C Wall
Journal:  Can Med Assoc J       Date:  1979-07-07       Impact factor: 8.262

3.  Chemotherapy for carcinoma of the bronchus--a brief review.

Authors:  N M Bleehen
Journal:  Postgrad Med J       Date:  1973-10       Impact factor: 2.401

Review 4.  The management of lung cancer.

Authors:  S G Spiro
Journal:  Lung       Date:  1982       Impact factor: 2.584

5.  Metastasis of a transplantable mammary tumour in rats treated with cyclophosphamide and/or irradiation.

Authors:  J V Moore; B Dixon
Journal:  Br J Cancer       Date:  1977-08       Impact factor: 7.640

6.  [Intra- or Postoperative Chemoprophylaxis? (author's transl)].

Authors:  H J Senn
Journal:  Langenbecks Arch Chir       Date:  1975-11

7.  Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group.

Authors: 
Journal:  BMJ       Date:  1995-10-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.